Detalhe da pesquisa
1.
A multiparametric niche-like drug screening platform in acute myeloid leukemia.
Blood Cancer J
; 12(6): 95, 2022 06 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-35750691
2.
Cystine uptake inhibition potentiates front-line therapies in acute myeloid leukemia.
Leukemia
; 36(6): 1585-1595, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35474100
3.
Clonal dominance is an adverse prognostic factor in acute myeloid leukemia treated with intensive chemotherapy.
Leukemia
; 35(3): 712-723, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-32581253
4.
The Folate Cycle Enzyme MTHFR Is a Critical Regulator of Cell Response to MYC-Targeting Therapies.
Cancer Discov
; 10(12): 1894-1911, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-32826232
5.
BET inhibitors impair leukemic stem cell function only in defined oncogenic subgroups of acute myeloid leukaemias.
Leuk Res
; 87: 106269, 2019 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31751766
6.
Relative Mitochondrial Priming Predicts Survival in Older AML Patients Treated Intensively.
Hemasphere
; 7(1): e819, 2023 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-36570694
7.
Hematopoietic differentiation at single-cell resolution in NPM1-mutated AML.
Blood Cancer J
; 12(9): 136, 2022 09 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-36151081